z-logo
Premium
Human virus‐specific CD8 + T cells: diversity specialists
Author(s) -
Van Leeuwen Ester M. M.,
De Bree Godelieve J.,
Ten Berge Ineke J. M.,
Van Lier René A. W.
Publication year - 2006
Publication title -
immunological reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.839
H-Index - 223
eISSN - 1600-065X
pISSN - 0105-2896
DOI - 10.1111/j.0105-2896.2006.00379.x
Subject(s) - biology , virus , effector , cd8 , virology , virus latency , cytotoxic t cell , immune system , immunology , latent virus , immunity , human cytomegalovirus , t cell , viral replication , genetics , in vitro
Summary:  Human viruses elicit functionally highly diverse CD8 + T‐cell responses. This variation, which manifests in the memory or latency stage, includes differences in expansion requirements, migratory properties, homeostatic maintenance mechanisms, and constitutive effector properties, and it may reflect specific adaptations of the human immune system to challenges posed by individual pathogens. Longitudinal follow‐up of individuals after primary virus infections has revealed how divergent virus‐specific CD8 + T cells may develop from the initially expanded virus‐specific T‐cell effector pool. Recent findings have shown that CD8 + T cells reactive toward latent viruses may depend on other mechanisms for their homeostatic maintenance than T cells specific for cleared viruses. Whereas the latter can respond to the homeostatic cytokine interleukin‐7 (IL‐7), many persistent virus‐specific T cells, recognizing latent herpesviruses such as Epstein–Barr virus and cytomegalovirus (CMV), lack IL‐7 receptor α (IL‐7Rα) and depend on viral antigens to persist. Finally, CMV is unique in that it generates a vast pool of resting virus‐specific T cells with constitutive cytolytic effector function. The putative role of functionally diverse CD8 + T cells in protective immunity to persistent viruses is discussed in this review.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here